Articles with public access mandates - Michael Snyder - Motor Neurone Disease Association, UKLearn more
NoteFor this mandate, articles should be available from specific locations.
Not available based on mandate: 1
BRAIN COMMUNICATIONS AIN COMMUNICATIONS
S Boddy, M Islam, T Moll, JKD Burrows, A McGown, A Bhargava, ...
Available based on mandate: 6
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication
T Moll, V Odon, C Harvey, MO Collins, A Peden, J Franklin, E Graves, ...
Life Science Alliance 6 (1), 2023
Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity
S Zhang, J Cooper-Knock, AK Weimer, M Shi, L Kozhaya, D Unutmaz, ...
Cell systems 13 (8), 598-614. e6, 2022
Mitochondrial function determines severity but not risk of amyotrophic lateral sclerosis
C Harvey, M Weinreich, S Zhang, PJ Hop, RAJ Zwamborn, K van Eijk, ...
BioRxiv, 2022.05. 31.494229, 2022
Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis
S Boddy, M Islam, T Moll, J Kurz, D Burrows, A McGown, A Bhargava, ...
Brain Communications 4 (2), fcac069, 2022
Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis
S Zhang, J Cooper-Knock, AK Weimer, M Shi, T Moll, JNG Marshall, ...
Neuron 110 (6), 992-1008. e11, 2022
Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene
J Cooper-Knock, S Zhang, KP Kenna, T Moll, JP Franklin, S Allen, ...
Cell Reports 33 (9), 2020
Publication and funding information is determined automatically by a computer program